Clinical Trial Update: Urinary NGAL and KIM-1 After ESWL

View source ↗

Summary

A completed clinical trial evaluating urinary biomarkers NGAL and KIM-1 after extracorporeal shock wave lithotripsy in patients with urinary stone disease and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Urolithiasis

Snippet

Sponsor: Marmara University | Conditions: Urinary Stone, Renal Injury | Status: COMPLETED